Endocrine resistance in breast cancer

Citations of this article
Mendeley users who have this article in their library.


Around 70% of all breast cancers are estrogen receptor alpha positive and hence their development is highly dependent on estradiol. While the invention of endocrine therapies has revolusioned the treatment of the disease, resistance to therapy eventually occurs in a large number of patients. This paper seeks to illustrate and discuss the complexity and heterogeneity of the mechanisms which underlie resistance and the approaches proposed to combat them. It will also focus on the use and development of methods for predicting which patients are likely to develop resistance.




Zheng, L. H., Zhao, Y. H., Feng, H. L., & Liu, Y. J. (2014). Endocrine resistance in breast cancer. Climacteric, 17(5), 522–528. https://doi.org/10.3109/13697137.2013.864268

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free